Skip to main content
. 2020 Sep 18;11:2142. doi: 10.3389/fimmu.2020.02142

Figure 4.

Figure 4

Prevalence of HHV-6A/B miRNAs in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) and other neurological diseases (OND) patients based on intrathecal antibody production and anti-HHV-6A/B IgG in CSF. The error bars depict the standard error of percentages. Pcorr, Bonferroni-corrected p-value.